Evidence map›Paper›PMID 41863549›Full record

ArticleEmerging infectious diseases2026

Home-Based Monitoring of Treatment-Related Adverse Events during Drug-Resistant Tuberculosis Treatment, India, 2020-2024.

Minal Ahson, Daksha Shah, Sampada Bhide, Rajesh Deshmukh, Jonathan P Smith, Smita Waghmare, Satish Kaipilyawar, Varsha Puri, Dilip K Khetade, Vijay Yeldandi and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Minal Ahson
Daksha Shah
Sampada Bhide
Rajesh Deshmukh
Jonathan P Smith
Smita Waghmare
Satish Kaipilyawar
Varsha Puri
Dilip K Khetade
Vijay Yeldandi
Anand Date
Patrick K Moonan
Christine S Ho

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated home-based outreach and point-of-care diagnostic tools for monitoring adverse events among persons treated for drug-resistant tuberculosis in Dharavi, India. Of 974 persons treated, 518 (53%) reported 1,410 adverse events, 126/477 (26%) required regimen change, and 83% of patients completed therapy. Home-based adverse event monitoring can help improve tuberculosis treatment adherence.

Indexed as

Antitubercular AgentsDrug MonitoringDrug-Related Side Effects and Adverse ReactionsTuberculosis, Multidrug-ResistantAdolescentAdultFemaleHumansIndiaMaleMiddle AgedYoung AdultAntitubercular Agentsantimicrobial resistancebacteriacommunity-based caredrug-related adverse reactionsextensively drug-resistant tuberculosisIndiamultidrug-resistant bacteriamultidrug-resistant tuberculosisMycobacterium tuberculosispharmacovigilancerespiratory infectionsTBtreatment adherenceTuberculosis and other mycobacteria

Identifiers

PMID41863549
PMCPMC13016008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.